Brighton Jones’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
Brighton Jones's PACB Position: Q3 2026 in Review
Brighton Jones sold out of Pacific Biosciences (PACB) in Q3 2026, closing a stake of 20,491 shares — an estimated $34.4K sold.
Brighton Jones first reported a position in PACB in Q1 2026 and held it in 2 quarters. The position peaked at $34.4K in Q2 2026. 160 funds tracked by Wall St. Rank hold PACB as of Q3 2026.
- Brighton Jones reported no remaining Pacific Biosciences position as of Q3 2026 after selling out during the quarter.
- Brighton Jones sold 20,491 Pacific Biosciences shares in Q3 2026, an estimated $34.4K.
- Brighton Jones first reported a position in Pacific Biosciences in Q1 2026 and held it in 2 quarters.
- Brighton Jones's Pacific Biosciences position peaked at $34.4K in Q2 2026.
- 160 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.